Neuberger Berman Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $204M | Buy |
|
|||||
2025
Q1 | $99.3M | Buy |
|
|||||
2024
Q4 | $28.2M | Buy |
|
|||||
2024
Q3 | $19.1M | Sell |
|
|||||
2024
Q2 | $16.4M | Sell |
|
|||||
2024
Q1 | $70.6M | Sell |
|
|||||
2023
Q4 | $451M | Buy |
|
|||||
2023
Q3 | $251M | Buy |
|
|||||
2023
Q2 | $240M | Buy |
|
|||||
2023
Q1 | $233M | Buy |
|
|||||
2022
Q4 | $18.7M | Buy |
|
|||||
2022
Q3 | $11.1M | Sell |
|
|||||
2022
Q2 | $20.9M | Sell |
|
|||||
2022
Q1 | $97.9M | Buy |
|
|||||
2021
Q4 | $16.5M | Buy |
|
|||||
2021
Q3 | $12.6M | Buy |
|
|||||
2021
Q2 | $12.1M | Buy |
|
|||||
2021
Q1 | $10.7M | Sell |
|
|||||
2020
Q4 | $89.2M | Buy |
|
|||||
2020
Q3 | $88.3M | Buy |
|
|||||
2020
Q2 | $105M | Buy |
|
|||||
2020
Q1 | $92.2M | Sell |
|
|||||
2019
Q4 | $223M | Sell |
|
|||||
2019
Q3 | $236M | Sell |
|
|||||
2019
Q2 | $262M | Buy |
|
|||||
2019
Q1 | $240M | Buy |
|
|||||
2018
Q4 | $208M | Sell |
|
|||||
2018
Q3 | $262M | Sell |
|
|||||
2018
Q2 | $277M | Buy |
|
|||||
2018
Q1 | $246M | Buy |
|
|||||
2017
Q4 | $221M | Buy |
|
|||||
2017
Q3 | $235M | Buy |
|
|||||
2017
Q2 | $183M | Buy |
|
|||||
2017
Q1 | $91.9M | Buy |
|
|||||
2016
Q4 | $75M | Buy |
|
|||||
2016
Q3 | $75.5M | Buy |
|
|||||
2016
Q2 | $39.4M | Buy |
|
|||||
2016
Q1 | $42.6M | Sell |
|
|||||
2015
Q4 | $61.4M | Buy |
|
|||||
2015
Q3 | $52.1M | Buy |
|
|||||
2015
Q2 | $31.2M | Buy |
|
|||||
2015
Q1 | $25.4M | Buy |
|
|||||
2014
Q4 | $10.7M | Sell |
|
|||||
2014
Q3 | $12.2M | Buy |
|
|||||
2014
Q2 | $8.56M | Buy |
|
|||||
2014
Q1 | $5.53M | Sell |
|
|||||
2013
Q4 | $6.39M | Sell |
|
|||||
2013
Q3 | $6.52M | Sell |
|
|||||
2013
Q2 | $7.02M | Buy |
|